Among them, TFE3-rearranged RCC, t(6;11) translocated (TFEB) RCC (Figure 7), FH-deficient RCC, SDH-deficient RCC (Figure 8), SMARCB1-deficient medullary RCC, ALK-rearranged RCC, and ELOC-mutated RCC are included. This evidence concerns the gene ALK and renal cell carcinoma.